LD-2 disclosure · 2nd Quarter - Report
ASTRAZENECA PHARMACEUTICALS LP
Client
- Description
- ​Biopharmaceutical Company.
- Location
- Delaware · United States of America
Registrant
- Description
- ​Government Affairs Consulting Firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Pediatric Priority Review Voucher Program. General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Global supply chain and investment issues. Prescription drug pricing policy.
LobbyistsDANIEL M TODD · PAUL EDATTEL · KATHERINE FLEMING COTTON · ERIC BERGREN · mr NICOLAS MAGALLANES
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office
Medicare/Medicaid
340B Program. Home Infusion for Part B Products. S.864: HELP Copays Act. Medicare Reimbursement for New Technologies.
LobbyistsDANIEL M TODD · PAUL EDATTEL · KATHERINE FLEMING COTTON · ERIC BERGREN · mr NICOLAS MAGALLANES
Covered position (DANIEL M TODD): Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
Covered position (PAUL EDATTEL): Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
Covered position (KATHERINE FLEMING COTTON): Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
Covered position (ERIC BERGREN): Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker